Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis. J of Skin [Internet]. 2024 Mar. 18 [cited 2026 Apr. 19];8(2):s373. Available from: https://skin.dermsquared.com/skin/article/view/2607